Streetbeat News

PMGM

Priveterra Acquisition Corp. II

Open

11.05

Mkt cap

61M

Volume

25K

High

11.06

P/E Ratio

52.62

52-wk high

11.21

Low

11.05

Div yield

N/A

52-wk low

10.75

Priveterra Acquisition Corp II received an additional notice from Nasdaq on April 29, indicating that the company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 8:04 pm

Priveterra Acquisition Corp (PMGM) has completed its business combination with AEON Biopharma, changing its name to AEON Biopharma and commencing trading on the NYSE under the ticker 'AEON'. AEON also announced the closing of funding arrangements of up to $125 million, which will help fund its clinical development of ABP-450 to treat various medical conditions.

Portfolio Pulse from Adam Eckert

July 24, 2023 | 2:14 pm

Priveterra Acquisition Corp. (NASDAQ:PMGM) has completed its business combination with AEON Biopharma, Inc., a Phase 3 stage-ready biopharmaceutical company. The combined company will be named AEON Biopharma, Inc. and will commence trading on NYSE under the ticker symbols 'AEON' and 'AEON WS' on July 24, 2023. Priveterra's CEO, Robert Palmisano, will join AEON's board as a Director.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 8:28 pm

Several stocks experienced significant movement in Friday's mid-day session. Notable gainers include Digital World Acquisition Corp. (DWAC), which jumped 69% after reaching a settlement with the SEC, and ServisFirst Bancshares, Inc. (SFBS), which rose 17.3% following positive Q2 results. On the other hand, Sigma Additive Solutions, Inc. (SASI) fell 34.6%, and Metropolitan Bank Holding Corp. (MCB) dipped 9.3% following weak quarterly results.

Portfolio Pulse from Lisa Levin

July 21, 2023 | 5:01 pm

U.S. stocks traded higher with the Dow Jones gaining around 50 points. American Express Company (AXP) reported better-than-expected earnings for its second quarter and reaffirmed its FY23 outlook. Digital World Acquisition Corp. (DWAC), Evelo Biosciences, Inc. (EVLO), and BioNexus Gene Lab Corp (BGLC) saw their shares rise significantly. Sigma Additive Solutions, Inc. (SASI), RedHill Biopharma Ltd. (RDHL), and Priveterra Acquisition Corp. (PMGM) experienced a drop in their shares.

Portfolio Pulse from Lisa Levin

July 21, 2023 | 1:53 pm

Priveterra Acquisition has been authorized to list on the NYSE following its business combination with AEON Biopharma. Post-merger, AEON will be a wholly owned subsidiary of Priveterra, which will change its name to AEON Biopharma, Inc. Trading under the new ticker symbol 'AEON' is expected to begin on July 24, 2023.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 9:04 pm

Lucid Group shares are trading higher by around 8% in pre-market trading after announcing a technology partnership with Aston Martin worth over $450 million. Other pre-market gainers include TRxADE HEALTH, Digital Media Solutions, and INVO Bioscience, while losers include Lulu's Fashion Lounge Holdings, Babylon Holdings, and SCWorx Corp.

Portfolio Pulse from Lisa Levin

June 26, 2023 | 12:19 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.